Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

spimaco, saudi arabia - memantine hydrochloride - film-coated tablet - 20 mg

Israel - English - Ministry of Health

a.l. medi-market ltd. - memantine hydrochloride - film coated tablets - memantine hydrochloride 10 mg - memantine - treatment of patient with moderate to severe alzheimer's disease.

Canada - English - Health Canada

alembic pharmaceuticals limited - memantine hydrochloride - tablet - 10mg - memantine hydrochloride 10mg - miscellaneous central nervous system agents

European Union - English - EMA (European Medicines Agency)

ratiopharm gmbh - memantine hydrochloride - alzheimer disease - psychoanaleptics, - treatment of patients with moderate to severe alzheimer’s disease

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva - memantine hydrochloride - tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zentiva - memantine hydrochloride - tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - memantine hydrochloride - tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - memantine hydrochloride - tablet - 10mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propantheline bromide, quantity: 15 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; sunset yellow fcf aluminium lake; iron oxide yellow; polyvinyl alcohol; macrogol 3350; lecithin; indigo carmine aluminium lake - this product accepted for registration as 'currently supplied' at the time of commencement of the act. indications were approved as specified in the letter of 7 april 1993 from dr l. hunt are as follows: as an adjunctive therapy in the treatment of peptic ulcer (gastric and duodenal), neurogenic bladder, urinary incontinence in patients with detrusor hyperactivity and hyperhidrosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease